Hubei Biocause Heilen Pharmaceutical Co., Ltd. Share Price
Equities
301211
CNE100005782
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.33 CNY | -1.57% | -8.10% | -24.92% |
Sales 2022 | 515M 71.08M 5.91B | Sales 2023 | 663M 91.52M 7.61B | Capitalization | 6.26B 865M 71.91B |
---|---|---|---|---|---|
Net income 2022 | 126M 17.39M 1.45B | Net income 2023 | 176M 24.3M 2.02B | EV / Sales 2022 | 12.4 x |
Net cash position 2022 | 1.95B 270M 22.44B | Net cash position 2023 | 1.82B 251M 20.86B | EV / Sales 2023 | 6.71 x |
P/E ratio 2022 |
66.6
x | P/E ratio 2023 |
35.7
x | Employees | 1,012 |
Yield 2022 |
1.15% | Yield 2023 |
2.21% | Free-Float | 24.56% |
1 day | -1.57% | ||
1 week | -8.10% | ||
Current month | -6.36% | ||
1 month | -3.66% | ||
3 months | -12.02% | ||
6 months | -34.65% | ||
Current year | -24.92% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Hao Yi
DFI | Director of Finance/CFO | 51 | 26/20/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ren Hui Fu
BRD | Director/Board Member | 44 | 20/23/20 |
Zhi Gang Cheng
CHM | Chairman | 50 | 26/20/26 |
Xue Qiang Huang
BRD | Director/Board Member | 57 | 26/20/26 |
Date | Price | Change | Volume |
---|---|---|---|
28/24/28 | 16.33 | -1.57% | 1 811 740 |
27/24/27 | 16.59 | -3.04% | 1,884,020 |
24/24/24 | 17.11 | +0.47% | 1,649,423 |
23/24/23 | 17.03 | -2.80% | 2,556,200 |
22/24/22 | 17.52 | +0.46% | 1,561,260 |
End-of-day quote Shenzhen S.E., May 28, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-24.92% | 660M | |
+38.05% | 727B | |
-7.64% | 354B | |
+15.77% | 328B | |
-0.19% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.96% | 164B | |
-2.01% | 164B |
- Stock Market
- Equities
- 301211 Stock